Veralto (VLTO) Q3 2025 10-Q Quarterly Report
Filed: Jul 28, 2025Period ending Jul 4, 2025
Health Care
Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR Veralto (VLTO) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Jul 28, 2025 for the fiscal period ending Jul 4, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Veralto Q3 2025 10-Q Analysis
Risk Factors
- • New insider trading risk: CEO adopted Rule 10b5-1 trading plan to sell 31,938 shares from May 28, 2025, to May 29, 2026
- • No material updates to risk factors disclosed this quarter per filing statements
Veralto Q3 2025 Quarterly FinancialsXBRL
Revenue
$1.4B
▲ +6.4% YoY▲ +2.9% QoQ
Net Income
$222M
▲ +9.4% YoY▼ -1.3% QoQ
Net Margin
16.2%
▲ +43bp YoY▼ -70bp QoQ
Source: XBRL data from Veralto Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Veralto Quarterly Reports
Get deeper insights on Veralto
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.